Abstract
Mortality among patients with COVID-19 and respiratory failure is high and there are no known lower airway biomarkers that predict clinical outcome. We investigated whether bacterial respiratory infections and viral load were associated with poor clinical outcome and host immune tone. We obtained bacterial and fungal culture data from 589 critically ill subjects with COVID-19 requiring mechanical ventilation. On a subset of the subjects that underwent bronchoscopy, we also quantified SARS-CoV-2 viral load, analyzed the microbiome of the lower airways by metagenome and metatranscriptome analyses and profiled the host immune response. We found that isolation of a hospital-acquired respiratory pathogen was not associated with fatal outcome. However, poor clinical outcome was associated with enrichment of the lower airway microbiota with an oral commensal (Mycoplasma salivarium), while high SARS-CoV-2 viral burden, poor anti-SARS-CoV-2 antibody response, together with a unique host transcriptome profile of the lower airways were most predictive of mortality. Collectively, these data support the hypothesis that 1) the extent of viral infectivity drives mortality in severe COVID-19, and therefore 2) clinical management strategies targeting viral replication and host responses to SARS-CoV-2 should be prioritized.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
R37 CA244775 (LNS, NCI/NIH); R01 HL125816 (LNS, SBK, NHLBI/NIH); Colton Pilot Project Grant (LNS, LA, SBL, KK); UWSC12030 (LNS, RP, LE, CDC Foundation); PACT grant (LNS, FNIH); R21 AI158997 (SK); R01 AI143861 (KMK, NIAID/NIH); R01 AI143861-02S1 (KMK, NIAID/NIH); R01 DK110014 (HL and CW, NIDDK/NIH); P20 CA252728 (CW and HL, NCI/NIH) American Association for Cancer Research Grant (HP/LNS); The Genome Technology Center is partially supported by the Cancer Center Support Grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center (AH, AT); FAMRI Young Clinical Scientist Award (BGW), Stony Wold-Herbert Fund Grant-in-Aid/Fellowship (IS, CB). This work was supported in part by the Division of Intramural Research (DIR) of the NIAID/NIH (EG, EDW).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the Institutional Review Board of New York University
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Imran Sulaiman, MD, PhD SheikMohammadImran.Sulaiman{at}nyumc.org
Matthew Chung, PhD matt.chung{at}nih.gov
Luis Angel, MD Luis.Angel{at}nyulangone.org
Jun-Chieh J. Tsay, MD jun-chieh.tsay{at}nyumc.org
Benjamin G. Wu, MD Benjamin.Wu{at}nyumc.org
Stephen Yeung, PhD Stephen.Yeung{at}nyulangone.org
Kelsey Krolikowski Kelsey.Krolikowski{at}nyulangone.org
Yonghua Li, MD, PhD Yonghua.Li{at}nyumc.org
Ralf Duerr, MD, PhD Ralf.Duerr{at}nyulangone.org
Rosemary Schluger, RN rosemary.schluger{at}nyumc.org
Sara A. Thannickal, BS Sara.thannickal{at}nyulangone.org
Akiko Koide, Phd, Akiko.Koide{at}nyulangone.org
Samaan Rafeq, MD Samaan.Rafeq{at}nyulangone.org
Clea Barnett, MD Clea.Barnett{at}nyulangone.org
Radu Postelnicu, MD Radu.Postelnicu{at}nyulangone.org
Chang Wang, PhD cw2505{at}nyu.edu
Stephanie Banakis stephanie.banakis{at}nih.gov
Lizzette Perez-Perez lizzette.perez-perez{at}nih.gov
George Jour, PhD George.Jour{at}nyulangone.org
Guomiao Shen, Phd Guomiao.Shen{at}nyulangone.org
Peter Meyn peter.meyn{at}nyumc.org
Joseph Carpenito Joseph.carpenito{at}nyumc.org
Xiuxiu Liu, MS liuxiuxiu_longhua{at}outlook.com
Kun Ji, MD, PhD Kun.Ji{at}nyulangone.org
Destiny Collazo Destiny.Collazo{at}nyulangone.org
Anthony Labarbiera Anthony.Labarbiera{at}nyulangone.org
Nancy Amoroso, MD Nancy.Amoroso{at}nyulangone.org
Shari Brosnahan, MD Shari.Brosnahan{at}nyulangone.org
Vikramjit Mukherjee, MD Vikramjit.Mukherjee{at}nyulangone.org
David Kaufman, MD David.A.Kaufman{at}nyulangone.org
Jan Bakker, MD, PhD Jan.Bakker{at}nyulangone.org
Anthony Lubinsky, MD Anthony.Lubinsky{at}nyulangone.org
Deepak Pradhan, MD Deepak.Pradhan{at}nyulangone.org
Daniel H. Sterman, MD Daniel.sterman{at}nyumc.org
Michael Weiden, MD Michael.Weiden{at}nyulangone.org
Adriana Heguy, PhD Adriana.heguy{at}nyumc.org
Laura Evans, MD leevans{at}uw.edu
Timothy M. Uyeki, MD, MPH tmu0{at}cdc.gov
Jose C. Clemente, PhD jose.clemente{at}mssm.edu
Emmie De wit emmie.dewit{at}nih.gov
Ann Marie Schmidt, MD AnnMarie.Schmidt{at}nyulangone.org
Bo Shopsin, MD, PhD Bo.Shopsin{at}nyulangone.org
Ludovic Desvignes, PhD Ludovic.Desvignes{at}nyulangone.org
Chan Wang, PhD Chan.Wang{at}nyulangone.org
Huilin Li, PhD Huilin.Li{at}nyulangone.org
Bin Zhang, PhD bin.zhang{at}mssm.edu
Christian V. Forst, PhD christian.forst{at}mssm.edu
Shohei Koide, PhD Shohei.Koide{at}nyulangone.org
Kenneth A. Stapleford, PhD Kenneth.Stapleford{at}nyulangone.org
Kamal Khanna, PhD Kamal.Khanna{at}nyulangone.org
Elodie Ghedin, PhD elodie.ghedin{at}nih.gov
Leopoldo N. Segal, MD Leopoldo.Segal{at}nyumc.org
Research support funding: R37 CA244775 (LNS, NCI/NIH); R01 HL125816 (LNS, SBK, NHLBI/NIH); Colton Pilot Project Grant (LNS, LA, SBL, KK); UWSC12030 (LNS, RP, LE, CDC Foundation); PACT grant (LNS, FNIH); R21 AI158997 (SK); R01 AI143861 (KMK, NIAID/NIH); R01 AI143861-02S1 (KMK, NIAID/NIH); R01 DK110014 (HL and CW, NIDDK/NIH); P20 CA252728 (CW and HL, NCI/NIH) American Association for Cancer Research Grant (HP/LNS); The Genome Technology Center is partially supported by the Cancer Center Support Grant P30CA016087 at the Laura and Isaac Perlmutter Cancer Center (AH, AT); FAMRI Young Clinical Scientist Award (BGW), Stony Wold-Herbert Fund Grant-in-Aid/Fellowship (IS, CB). This work was supported in part by the Division of Intramural Research (DIR) of the NIAID/NIH (EG, EDW).
Financial Disclosure: None
There was an error noted in the supplementary figures. An amended PPT with the supplementary figures has been uploaded
Data Availability
Sequencing data are available in NCBI's Sequence Read Archive at the links provided bellow.
